UNSPSC 51391811: Methoxyphenamine hydrochloride

This classification denotes a beta-adrenergic agonist with the molecular formula C11H17NO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 52V8BVV7FX, chemically known as 2-methoxy-n,alpha-dimethylphenethylamin but more generally known as methoxyphenamine hydrochloride, which bears US NIH Compound Identifier 4117. European Medicines Agency schedules Methoxyphenamine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03229MIG.

Most nations, for tariff and trade purposes, schedule methoxyphenamine hydrochloride under HS 29222900 and SITC 51462. As of Q4 2014, METHOXYPHENAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Methoxyphenamine hydrochloride bears US NLM identifiers UMLS ID C0770481 and NCI Concept Code C83959. SMILES: CC(CC1CCCCC1OC)NC.CL.

UNSPSC 51391811 Methoxyphenamine hydrochloride is a Commodity code that shows limited alignment with the recent state and local opportunities posted under it. The two most recent records tagged to this code involve naloxone procurement and therapeutic pharmacy initiative direct-to-manufacturer prescriptions — neither of which involves methoxyphenamine hydrochloride specifically. Seminole County, Florida's IFB for naloxone and drug deactivation systems targets a public health use case (community health support through opioid-reversal medication), while the Texas Health and Human Services Commission's RFI explores pharmacy benefit program restructuring and direct manufacturer contracting models. The code's nominal scope — a specific pharmaceutical compound — does not match the actual procurement activity the state and local records show, suggesting either miscoding in the source material or minimal real-world solicitation volume for methoxyphenamine hydrochloride itself under this code.

The geographic activity visible in the recent records spans Florida and Texas, with Seminole County issuing a competitive IFB (posted June 30, 2026, response due July 26, 2023) and the Texas HHS Commission issuing an exploratory RFI (posted April 3, 2026, response due April 3, 2026). The Seminole County opportunity involves straightforward product procurement with quarterly deliveries, E-Verify compliance, and fixed-fee pricing; the Texas RFI is preliminary market intelligence gathering rather than a formal solicitation with budget or award timeline. No recent opportunities directly procuring methoxyphenamine hydrochloride under this code appear in the source material, indicating this Commodity code sees little relevant current activity in state and local procurement.